Senti Biosciences (SNTI) Short Interest Ratio & Short Volume → Buy this small stock before coming AI Tidal Wave (From Chaikin Analytics) (Ad) Free SNTI Stock Alerts $0.38 0.00 (0.00%) (As of 05/17/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Senti Biosciences Short Interest DataCurrent Short Volume287,300 sharesPrevious Short Volume165,200 sharesChange Vs. Previous Month+73.91%Dollar Volume Sold Short$103,428.00Short Interest Ratio / Days to Cover2.5Last Record DateApril 30, 2024Outstanding Shares45,760,000 sharesFloat Size27,380,000 sharesShort Percent of Float1.05%Today's Trading Volume64,661 sharesAverage Trading Volume178,279 sharesToday's Volume Vs. Average36% Short Selling Senti Biosciences ? Sign up to receive the latest short interest report for Senti Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSNTI Short Interest Over TimeSNTI Days to Cover Over TimeSNTI Percentage of Float Shorted Over Time Ad Porter & CompanyHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that will forever enshrine Obama’s destructive, Marxist vision for America… A plot that could hand him and his allies near-total control over the government, your way of life, and your future.Click here to watch this now before it’s too late. Senti Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024287,300 shares $103,428.00 +73.9%1.1%2.5 $0.36 4/15/2024165,200 shares $49,758.24 -22.7%0.6%2 $0.30 3/31/2024213,800 shares $80,623.98 -4.2%0.8%2.1 $0.38 3/15/2024223,200 shares $83,253.60 -17.3%0.8%0.3 $0.37 2/29/2024269,900 shares $116,057.00 -21.9%1.0%0.4 $0.43 2/15/2024345,400 shares $146,795.00 +15.1%1.3%0.5 $0.43 Get the Latest News and Ratings for SNTI and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Senti Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024300,000 shares $135,030.00 -30.4%1.2%0.1 $0.45 1/15/2024430,700 shares $232,147.30 -44.1%1.6%0.2 $0.54 12/31/2023769,900 shares $508,134.00 +60.8%2.9%0.3 $0.66 12/15/2023478,900 shares $182,987.69 -42.6%1.8%0.2 $0.38 11/30/2023834,000 shares $358,703.40 -44.4%3.2%0.3 $0.43 11/15/20231,500,000 shares $557,700.00 +260.1%5.7%0.6 $0.37 10/31/2023416,500 shares $116,536.70 -8.2%1.6%0.2 $0.28 10/15/2023453,800 shares $137,002.22 +100.6%1.7%1.6 $0.30 9/30/2023226,200 shares $93,420.60 +7.2%0.9%0.9 $0.41 9/15/2023211,000 shares $122,823.10 -32.7%0.8%2.9 $0.58 8/31/2023313,400 shares $203,710.00 -6.8%1.5%4.6 $0.65 8/15/2023336,300 shares $242,472.30 -10.1%1.6%4.8 $0.72 7/31/2023374,200 shares $322,560.40 -12.3%1.9%5.3 $0.86 7/15/2023426,500 shares $298,550.00 +24.9%2.1%4.4 $0.70 6/30/2023341,400 shares $214,057.80 -15.1%1.4%3.5 $0.63 6/15/2023402,300 shares $402,300.00 -12.8%1.6%4.6 $1.00 5/31/2023461,100 shares $407,566.29 -11.0%1.8%5.3 $0.88 5/15/2023517,900 shares $502,363.00 +2.9%2.0%5.8 $0.97 4/30/2023503,500 shares $493,430.00 -0.5%1.9%5.4 $0.98 4/15/2023506,100 shares $541,527.00 +0.2%2.0%4.9 $1.07 3/31/2023505,200 shares $596,136.00 -9.0%2.0%5.3 $1.18 3/15/2023555,200 shares $705,104.00 +12.6%2.2%5.4 $1.27 2/28/2023493,100 shares $739,650.00 -4.4%1.9%2.7 $1.50 2/15/2023515,500 shares $860,885.00 -13.1%2.0%2.8 $1.67 1/31/2023593,300 shares $1.09 million -5.1%1.7%2.8 $1.83 1/15/2023625,100 shares $1.18 million +1.6%1.8%2.4 $1.89 12/30/2022615,500 shares $867,855.00 +65.6%1.8%0.9 $1.41 12/15/2022371,800 shares $565,136.00 -12.3%1.1%0.1 $1.52 11/30/2022423,900 shares $974,970.00 -6.8%1.2%0.1 $2.30 11/15/2022454,700 shares $1.10 million -12.0%1.3%0.1 $2.43 10/31/2022516,900 shares $1.20 million -20.1%1.5%0.1 $2.32 10/15/2022646,600 shares $2.11 million -1.8%1.9%0.1 $3.27 9/30/2022658,400 shares $1.43 million +265.6%1.9%0.1 $2.17 9/15/2022180,100 shares $405,225.00 -23.0%0.5%0.1 $2.25He called Apple at $1.49 and now he says: “Buy these 6 AI stocks.” (Ad)For over four decades, Louis Navellier has found the very best tech stocks... Before the rest of the market.Click for his six specific AI stock in the crosshairs SNTI Short Interest - Frequently Asked Questions What is Senti Biosciences' current short interest? Short interest is the volume of Senti Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 287,300 shares of SNTI short. 1.05% of Senti Biosciences' shares are currently sold short. Learn More on Senti Biosciences' current short interest. What is a good short interest ratio for Senti Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. SNTI shares currently have a short interest ratio of 2.0. Learn More on Senti Biosciences's short interest ratio. What is a good short interest percentage for Senti Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.05% of Senti Biosciences' floating shares are currently sold short. Is Senti Biosciences' short interest increasing or decreasing? Senti Biosciences saw a increase in short interest during the month of April. As of April 30th, there was short interest totaling 287,300 shares, an increase of 73.9% from the previous total of 165,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Senti Biosciences' float size? Senti Biosciences currently has issued a total of 45,760,000 shares. Some of Senti Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Senti Biosciences currently has a public float of 27,380,000 shares. How does Senti Biosciences' short interest compare to its competitors? 1.05% of Senti Biosciences' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Senti Biosciences: PharmaCyte Biotech, Inc. (0.17%), Aptose Biosciences Inc. (0.86%), Evaxion Biotech A/S (0.98%), Coeptis Therapeutics Holdings, Inc. (0.57%), ZIVO Bioscience, Inc. (4.24%), Genetic Technologies Limited (0.58%), BioCardia, Inc. (0.96%), Organovo Holdings, Inc. (4.09%), Creative Medical Technology Holdings, Inc. (1.55%), Titan Pharmaceuticals, Inc. (1.99%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Senti Biosciences stock? Short selling SNTI is an investing strategy that aims to generate trading profit from Senti Biosciences as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Senti Biosciences? A short squeeze for Senti Biosciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of SNTI, which in turn drives the price of the stock up even further. How often is Senti Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNTI, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: PharmaCyte Biotech Short Interest Aptose Biosciences Short Interest Evaxion Biotech A/S Short Interest Coeptis Therapeutics Short Interest ZIVO Bioscience Short Interest Genetic Technologies Short Interest BioCardia Short Interest Organovo Short Interest Creative Medical Technology Short Interest Titan Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:SNTI) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaMissed NVDA? Buy this AI stock NOWChaikin AnalyticsUrgent Nvidia WarningAltimetryCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingMost important medical advance in 100 yearsThe Oxford ClubNext President (Not Trump. Not Biden.)The Freeport SocietyCrypto Pioneer Says: “The last crypto bull market has begun.”InvestorPlaceProtect Your Bank Account Before It’s Too LateWeiss Ratings